ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

IOBT IO Biotech Inc

1.48
-0.05 (-3.27%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
IO Biotech Inc IOBT NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.05 -3.27% 1.48 06:30:01
始値 安値 高値 終値 前日終値
1.53 1.48 1.58 1.48 1.53
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2505:30GLOBEIO Biotech Announces Abstract Accepted for Presentation at..
2024/4/1521:30GLOBEIO Biotech Expands Senior Leadership Team to Progress..
2024/4/1001:00GLOBEIO Biotech Presents New Data at AACR 2024 Further Supporting..
2024/4/0521:30GLOBEIO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business..
2024/3/1205:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0706:11GLOBEIO Biotech Announces Acceptance of Abstract to be Presented..
2024/3/0607:17EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0606:46EDGAR2Form 8-K - Current report
2024/3/0606:40GLOBEIO Biotech Announces 2023 Fourth-Quarter and Year-End..
2024/2/2706:05GLOBEIO Biotech to Present at 44th Annual Cowen Health Care..
2024/1/0822:11EDGAR2Form 8-K - Current report
2023/12/2122:30GLOBEIO Biotech Announces First Patient Dosed in Phase 2..
2023/11/2507:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1406:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1322:12GLOBEIO Biotech Announces 2023 Third Quarter Results
2023/11/1322:10EDGAR2Form 8-K - Current report
2023/11/1322:00GLOBEIO Biotech Appoints Helen Collins, MD, to its Board of..
2023/11/1022:00GLOBEIO Biotech Completes Enrollment of 380 Patients in Pivotal..
2023/11/0906:30GLOBEIO Biotech Announces Participation in Upcoming Investor..
2023/11/0121:30GLOBEIO Biotech Presents Three Posters at the Society for..
2023/10/2314:00GLOBEEncouraging Preliminary Data from a Phase 2 Trial Evaluating..
2023/10/0405:30GLOBEIO Biotech Announces Three Poster Presentations at the..
2023/9/1305:06EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
2023/9/1221:05GLOBEIO Biotech Announces New Data Related to its IO102-IO103..
2023/9/1113:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/9/0723:36EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/9/0621:35GLOBEIO Biotech Announces Participation in Upcoming Investor..
2023/8/3105:16EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/8/1607:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1606:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/8/1210:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1121:41EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1121:31EDGAR2Form 8-K - Current report
2023/8/1121:30GLOBEIO Biotech Announces 2023 Second Quarter Results
2023/8/1121:05GLOBEIO Biotech Appoints Heidi Hunter to its Board of Directors
2023/8/1009:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1009:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0821:05GLOBEIO Biotech Announces Abstract Accepted for Poster..
2023/8/0721:31EDGAR2Form 8-K - Current report
2023/8/0721:30GLOBEIO Biotech, Inc. Announces $75 Million Private Placement..
2023/7/2821:05GLOBEIO Biotech Announces First Patient Dosed in..
2023/7/2605:05GLOBEIO Biotech Announces Abstract Accepted for Mini Oral..
2023/7/2005:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/2005:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/7/1905:05EDGAR2Form 8-K - Current report
2023/7/1905:05GLOBEIO Biotech Strengthens Executive Management and US Presence..
2023/6/1421:00GLOBEIO Biotech Announces Achievement of Significant Phase 3..
2023/6/0121:30GLOBEIO Biotech Appoints Christine Richter, Ph.D., MBA, as Senior..

最近閲覧した銘柄

Delayed Upgrade Clock